SUMMARY The feasibility of internal cardioversion for ventricular tachycardia using a prototype of an implantable cardioverter which delivers a low energy discharge via an intracardiac lead and its acceptability to the patient were studied. The cardioverting discharge was synchronised to the apical right ventricular electrogram. In 29 episodes of-ventricular tachycardia (RR interval 250-700 ms) the apical electrogram was reliably sensed. The interval from the onset of the QRS complex to the marker of sensing of the electrogram was significantly greater in the 15 episodes arising from the left ventricle than in the 14 episodes arising from the right ventricle; in three cases of ventricular tachycardia arising from the left ventricle the interval exceeded 100 ms. In all cases except one, however, sensing occurred within the first 800/o of the QRS complex. In two episodes (RR interval 150 and 190 ms-that is, less than the refractory period of the unit) sensing of the electrogram was unreliable. The unit successfully terminated 10 of 15 episodes of ventricular tachycardia using energies ranging between 0 01 and 1.0 J, but 19 of the 23 discharges delivered to conscious patients caused varying degrees of discomfort. Sensing within 100 ms of the onset of the QRS complex (-20% to 83% of QRS) permitted effective and safe termination of ventricular tachycardia. Although there was neither acceleration of tachycardia nor ventricular fibrillation, subthreshold discharges advanced the next local ventricular electrogram in seven instances. An external low energy cardioverter connected to an intracardiac lead is a useful alternative to repeated external direct current shocks.
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Although drugs remain the mainstay in the treatment and prevention of recurrent ventricular tachycardia, there is a group of patients in whom antiarrhythmic drugs are ineffective or in whom the negative inotropism precludes their use. Electrical methods, including pacemakers, may be used but usually require the presence of experienced personnel and often admission to hospital. External direct current cardioversion/ defibrillation delivered across the thorax is the most effective method but requires a high energy source. Low energies (<2-5 J) delivered directly to the Requests for reprints to Dr M S Perelman, Division of Cardiovascular Disease, Royal Postgraduate Medical School, Hammersmith Hospital, Ducane Road, London W12 OHS.
Accepted for publication 7 June 1984 myocardium via a transvenous lead terminate ventricular tachycardia in over 830/o of cases. ' -I Previous studies have used a modified external defibrillator as the energy source,' 2 whereas in this study we used a prototype of a fully implantable cardioverter (Medtronic 2342, refractory period 205 ms). With this unit the apical right ventricular electrogram was used to synchronise the delivery of the discharges.
Initially, we examined the synchronisation of sensing, by the cardioverter, to the apical right ventricular electrogram and to the QRS complex during episodes of ventricular tachycardia. Later the prototype cardioverter was used to terminate episodes of ventricular tachycardia, whether occurring spontaneously or induced during routine diagnostic electrophysiological studies. 385 386
Patients and methods
Thirty one separate episodes of ventricular tachycardia previously recorded during electrophysiological studies were played back using a Racal Thermionic 14 channel tape recorder (frequency response DC to 400 Hz). The surface electrocardiogram (leads I, III, V1, and V6) together with the apical right ventricular electrogram were displayed on a 12 channel electrocardiograph (Siemens-Elema mingograph). The apical right ventricular electrogram, after being attenuated to approximately 5 mV, was simultaneously delivered to the sensing channel of the cardioverter. The sensitivity of sensing by the cardioverter was adjusted (range 0 5-10 mV) so that each ventricular complex was correctly sensed. A marker of sensing, generated by the cardioverter, was displayed together with the original electrical signals at a paper speed of 100 mm/s (Fig. 1) ; this marker indicates the time at which a cardioverting discharge would be delivered had the unit been activated. The intervals from the onset of the QRS complex and from the onset of the apical right ventricular electrogram to the marker of sensing were calculated over 20 consecutive complexes selected at random from each episode of ventricular tachycardia.
The right or left ventricular origin of the tachycardias was determined by endocardial mapping performed at the time of the original electrophysiological study.
STUDY POPULATION
Nine patients with recurrent sustained ventricular tachycardia resistant to drug treatment were investigated after informed written consent had been obtained; the study was approved by the research and Perelman, Rowland, Krikler ethics committee of our institution. All patients had been admitted for routine diagnostic electrophysiological study; the connected and act as the anode. The leads are made with three different distances between the proximal and distal pairs of electrodes: 100, 125, and 150 mm; in most cases we used leads with a separation of 125 mm so that the proximal pair of electrodes was positioned in the high right atrium.
The cardioverting lead was inserted, under local anaesthesia, into one of the subclavian veins and advanced under x ray screening to the right ventricle and positioned so that the tip lay at the apex of the right ventricle and the proximal electrodes were in the superior vena cava or high right atrium, usually the latter. The impedance and pacing threshold were measured before and after any discharges as a check against dislodgement. During the electrophysiological studies the stability of the electrode was confirmed by radiography. The apical right ventricular electrogram (recorded from the two distal electrodes of the cardioverting lead) was played directly into the cardioverter and the sensitivity adjusted (0.5-10 mV) for accurate and reliable sensing. The cardioverter is a battery powered unit which produces a monophasic, truncated, exponential discharge with a pulse duration of 5 5 ms when delivered into a load of 100 Ql. The energy delivered can be varied in 10 fixed steps between 0*01 and 5 J. Once the unit is activated it automatically delivers a discharge, at a predetermined energy level, synchronised to the apical right ventricular electrogram.
For the electrophysiological study two or three more electrodes were inserted via the right femoral vein and positioned in the high right atrium and in the right ventricle. Ventricular tachycardia was induced either by incremental ventricular pacing or by pacing at a regular rate followed by single or double ventricular stimuli. group.bmj.com on January 6, 2018 -Published by http://heart.bmj.com/ Downloaded from Assessment of a prototype implantable cardioverter for ventricular tachycardia plexes were sensed with a variable delay between the electrogram and the marker of sensing (Fig. 3) , although sensing always fell within the QRS complex. In the second (RR interval 190 ms) the interval from the onset of the QRS complex to the marker of sensing progressively increased (Fig. 4) possibly because ventricular activity persisted beyond the blanking period of the unit (205 ms). During this episode of tachycardia the marker of sensing often fell outside the QRS complex (10-0 ms).
EFFECT ON THE TACHYCARDIA Twenty nine discharges were delivered to nine patients during 15 separate episodes of ventricular tachycardia (Table) , 11 of which arose from the left ventricle and four from the right ventricle (Fig. 5) . In all episodes the apical right ventricular electrogram was sensed reliably and consistently. In three of the four episodes of tachycardia arising from the right (QS/QRS 83%), but this episode was terminated without acceleration or advancement.
Ten of the 15 episodes of ventricular tachycardia were successfully terminated by energies ranging between 0*01 and 1X0 J (Table) . In six episodes the first energy level selected was successful. Although in four other episodes a series of discharges of increasing energy were required for termination (Fig. 6) , the mean threshold for termination was 0-67 J.
There were five episodes where transvenous cardioversion did not terminate the tachycardia (Table) . In one the tachycardia terminated spontaneously after two subthreshold discharges. On three occasions the lowest energy setting (0-01 J) was associated with such severe discomfort or pain that higher energies In no case did the tachycardia accelerate or degenerate into ventricular fibrillation, although in one case successful termination was followed by three repetitive ventricular complexes and a brief run of atrial fibrillation; sinus rhythm spontaneously returned after 30 seconds. In seven instances subthreshold discharges advanced the next ventricular electrogram (10-20 ms) without accelerating the tachycardia. This brief change in cycle length was unrelated to the energy delivered.
PATIENT REACTION Eight of the nine patients were fully conscious at the time of cardioversion. Six patients experienced either moderate or severe discomfort while the remaining two felt only minor discomfort. In most patients there appeared to be no relation between the energy used and the degree of discomfort experienced. Typically, the discharges were felt in the chest, although in one patient it was felt in the upper abdomen. The shocks were likened either to a "kick in the chest" or a "heavy hiccup." Five of the eight patients who remained conscious required multiple discharges at increasing energy levels. Three felt increasing pain with the rising energy level whereas in the other two the level of discomfort was similar. One of these described the third discharge, with the highest energy (1.0 J), as the "easiest," possibly because this resulted in a return to sinus rhythm.
On three of the four occasions on which the lowest energy available was delivered (0-01 J) the discharges caused severe pain, which in one patient was associated with involuntary hip flexion. In this patient the lead tip was repositioned against the anterior wall in the body of the right ventricle, but a second discharge of the same strength also caused pain. A second patient also experienced voluntary hip flexion, although on this occasion with a discharge of 0 5 J. The clinical use of low energies (0.25-2-0 J) for the termination of recurrent ventricular tachyarrhythmias was first reported by Zipes et al.12 The energy source was an external defibrillator in which the output had been attenuated. The technique was successful in five of seven patients; in three the cardioversion threshold was -0-25 J. Forty two of the 47 successful discharges were delivered to patients who were concurrently receiving antiarrhythmic drugs, but the one episode of induced acceleration also occurred in a patient receiving antiarrhythmic medication. Waspe et al compared low energy transvenous countershock with pacing for the termination of ventricular tachycardia8; they found no significant difference in their success rates, but seven of 50 episodes were accelerated by synchronised transvenous countershock, a phenomenon that they did not observe with pacing. Their results support the observations that successful termination can be correlated with a longer cycle length of the ventricular tachycardia,7 while others have shown that acceleration is more likely with ventricular tachycardias of short cycle length (<200 ms).7
In our study 10 of 15 (75%) episodes of ventricular tachycardia were successfully terminated; the mean threshold for termination was 0-67 J. In four of the five failures we were prevented from using higher energies because of discomfort associated with the discharges or because of spontaneous termination. Although the numbers are small our data suggest an inverse relation between the threshold for termination and the cycle length of the ventricular tachycardia.
Jackman and Zipes have shown that the timing of the discharge within the QRS complex is important.7 Discharges occurring within the first 80% of the QRS complex rarely caused even repetitive ventricular responses, while discharges in the terminal 20% of the QRS complex easily induced acceleration or degeneration. With a fully automatic implantable cardioverter the apical right ventricular electrogram could be used both to sense the ventricular tachycardia and to synchronise the delivery of the cardioverting discharge.
